1333 related articles for article (PubMed ID: 31272512)
1. Associations between quantitative [
Timmers T; Ossenkoppele R; Wolters EE; Verfaillie SCJ; Visser D; Golla SSV; Barkhof F; Scheltens P; Boellaard R; van der Flier WM; van Berckel BNM
Alzheimers Res Ther; 2019 Jul; 11(1):60. PubMed ID: 31272512
[TBL] [Abstract][Full Text] [Related]
2. Regional [
Wolters EE; Ossenkoppele R; Verfaillie SCJ; Coomans EM; Timmers T; Visser D; Tuncel H; Golla SSV; Windhorst AD; Boellaard R; van der Flier WM; Teunissen CE; Scheltens P; van Berckel BNM
Eur J Nucl Med Mol Imaging; 2020 Nov; 47(12):2866-2878. PubMed ID: 32291510
[TBL] [Abstract][Full Text] [Related]
3. Hippocampal [
Wolters EE; Ossenkoppele R; Golla SS; Verfaillie SC; Timmers T; Visser D; Tuncel H; Coomans EM; Windhorst AD; Scheltens P; van der Flier WM; Boellaard R; van Berckel BN
Neuroimage Clin; 2020; 25():102113. PubMed ID: 31835238
[TBL] [Abstract][Full Text] [Related]
4. Regional profiles of the candidate tau PET ligand 18F-AV-1451 recapitulate key features of Braak histopathological stages.
Schwarz AJ; Yu P; Miller BB; Shcherbinin S; Dickson J; Navitsky M; Joshi AD; Devous MD; Mintun MS
Brain; 2016 May; 139(Pt 5):1539-50. PubMed ID: 26936940
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic Performance of RO948 F 18 Tau Positron Emission Tomography in the Differentiation of Alzheimer Disease From Other Neurodegenerative Disorders.
Leuzy A; Smith R; Ossenkoppele R; Santillo A; Borroni E; Klein G; Ohlsson T; Jögi J; Palmqvist S; Mattsson-Carlgren N; Strandberg O; Stomrud E; Hansson O
JAMA Neurol; 2020 Aug; 77(8):955-965. PubMed ID: 32391858
[TBL] [Abstract][Full Text] [Related]
6. 18F-flortaucipir PET to autopsy comparisons in Alzheimer's disease and other neurodegenerative diseases.
Soleimani-Meigooni DN; Iaccarino L; La Joie R; Baker S; Bourakova V; Boxer AL; Edwards L; Eser R; Gorno-Tempini ML; Jagust WJ; Janabi M; Kramer JH; Lesman-Segev OH; Mellinger T; Miller BL; Pham J; Rosen HJ; Spina S; Seeley WW; Strom A; Grinberg LT; Rabinovici GD
Brain; 2020 Dec; 143(11):3477-3494. PubMed ID: 33141172
[TBL] [Abstract][Full Text] [Related]
7. Tau pathology and relative cerebral blood flow are independently associated with cognition in Alzheimer's disease.
Visser D; Wolters EE; Verfaillie SCJ; Coomans EM; Timmers T; Tuncel H; Reimand J; Boellaard R; Windhorst AD; Scheltens P; van der Flier WM; Ossenkoppele R; van Berckel BNM
Eur J Nucl Med Mol Imaging; 2020 Dec; 47(13):3165-3175. PubMed ID: 32462397
[TBL] [Abstract][Full Text] [Related]
8. Test-Retest Reproducibility for the Tau PET Imaging Agent Flortaucipir F 18.
Devous MD; Joshi AD; Navitsky M; Southekal S; Pontecorvo MJ; Shen H; Lu M; Shankle WR; Seibyl JP; Marek K; Mintun MA
J Nucl Med; 2018 Jun; 59(6):937-943. PubMed ID: 29284675
[TBL] [Abstract][Full Text] [Related]
9. Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's disease.
Maass A; Landau S; Baker SL; Horng A; Lockhart SN; La Joie R; Rabinovici GD; Jagust WJ;
Neuroimage; 2017 Aug; 157():448-463. PubMed ID: 28587897
[TBL] [Abstract][Full Text] [Related]
10. MRI and flortaucipir relationships in Alzheimer's phenotypes are heterogeneous.
Josephs KA; Tosakulwong N; Graff-Radford J; Weigand SD; Buciuc M; Machulda MM; Jones DT; Schwarz CG; Senjem ML; Ertekin-Taner N; Kantarci K; Boeve BF; Knopman DS; Jack CR; Petersen RC; Lowe VJ; Whitwell JL
Ann Clin Transl Neurol; 2020 May; 7(5):707-721. PubMed ID: 32293805
[TBL] [Abstract][Full Text] [Related]
11. Tau pathology as determinant of changes in atrophy and cerebral blood flow: a multi-modal longitudinal imaging study.
Visser D; Verfaillie SCJ; Bosch I; Brouwer I; Tuncel H; Coomans EM; Rikken RM; Mastenbroek SE; Golla SSV; Barkhof F; van de Giessen E; van Berckel BNM; van der Flier WM; Ossenkoppele R
Eur J Nucl Med Mol Imaging; 2023 Jul; 50(8):2409-2419. PubMed ID: 36976303
[TBL] [Abstract][Full Text] [Related]
12. Relationships Between Cognition and Neuropathological Tau in Alzheimer's Disease Assessed by 18F Flortaucipir PET.
Devous MD; Fleisher AS; Pontecorvo MJ; Lu M; Siderowf A; Navitsky M; Kennedy I; Southekal S; Harris TS; Mintun MA
J Alzheimers Dis; 2021; 80(3):1091-1104. PubMed ID: 33682705
[TBL] [Abstract][Full Text] [Related]
13. Region-Specific Association of Subjective Cognitive Decline With Tauopathy Independent of Global β-Amyloid Burden.
Buckley RF; Hanseeuw B; Schultz AP; Vannini P; Aghjayan SL; Properzi MJ; Jackson JD; Mormino EC; Rentz DM; Sperling RA; Johnson KA; Amariglio RE
JAMA Neurol; 2017 Dec; 74(12):1455-1463. PubMed ID: 28973551
[TBL] [Abstract][Full Text] [Related]
14. [F-18]-AV-1451 binding correlates with postmortem neurofibrillary tangle Braak staging.
Marquié M; Siao Tick Chong M; Antón-Fernández A; Verwer EE; Sáez-Calveras N; Meltzer AC; Ramanan P; Amaral AC; Gonzalez J; Normandin MD; Frosch MP; Gómez-Isla T
Acta Neuropathol; 2017 Oct; 134(4):619-628. PubMed ID: 28612291
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal 18F-MK-6240 tau tangles accumulation follows Braak stages.
Pascoal TA; Benedet AL; Tudorascu DL; Therriault J; Mathotaarachchi S; Savard M; Lussier FZ; Tissot C; Chamoun M; Kang MS; Stevenson J; Massarweh G; Guiot MC; Soucy JP; Gauthier S; Rosa-Neto P
Brain; 2021 Dec; 144(11):3517-3528. PubMed ID: 34515754
[TBL] [Abstract][Full Text] [Related]
16. Sensitivity-Specificity of Tau and Amyloid β Positron Emission Tomography in Frontotemporal Lobar Degeneration.
Ghirelli A; Tosakulwong N; Weigand SD; Clark HM; Ali F; Botha H; Duffy JR; Utianski RL; Buciuc M; Murray ME; Labuzan SA; Spychalla AJ; Pham NTT; Schwarz CG; Senjem ML; Machulda MM; Baker M; Rademakers R; Filippi M; Jack CR; Lowe VJ; Parisi JE; Dickson DW; Josephs KA; Whitwell JL
Ann Neurol; 2020 Nov; 88(5):1009-1022. PubMed ID: 32869362
[TBL] [Abstract][Full Text] [Related]
17. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
Pontecorvo MJ; Devous MD; Navitsky M; Lu M; Salloway S; Schaerf FW; Jennings D; Arora AK; McGeehan A; Lim NC; Xiong H; Joshi AD; Siderowf A; Mintun MA;
Brain; 2017 Mar; 140(3):748-763. PubMed ID: 28077397
[TBL] [Abstract][Full Text] [Related]
18. Does inflammation precede tau aggregation in early Alzheimer's disease? A PET study.
Parbo P; Ismail R; Sommerauer M; Stokholm MG; Hansen AK; Hansen KV; Amidi A; Schaldemose JL; Gottrup H; Brændgaard H; Eskildsen SF; Borghammer P; Hinz R; Aanerud J; Brooks DJ
Neurobiol Dis; 2018 Sep; 117():211-216. PubMed ID: 29902557
[TBL] [Abstract][Full Text] [Related]
19. In vivo measures of tau burden are associated with atrophy in early Braak stage medial temporal lobe regions in amyloid-negative individuals.
Das SR; Xie L; Wisse LEM; Vergnet N; Ittyerah R; Cui S; Yushkevich PA; Wolk DA;
Alzheimers Dement; 2019 Oct; 15(10):1286-1295. PubMed ID: 31495603
[TBL] [Abstract][Full Text] [Related]
20. White Matter Degeneration Pathways Associated With Tau Deposition in Alzheimer Disease.
Tian J; Raghavan S; Reid RI; Przybelski SA; Lesnick TG; Gebre RK; Graff-Radford J; Schwarz CG; Lowe VJ; Kantarci K; Knopman DS; Petersen RC; Jack CR; Vemuri P
Neurology; 2023 May; 100(22):e2269-e2278. PubMed ID: 37068958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
